Which pharmaceutical company launched the first FDA-approved monoclonal antibody treatment for multiple sclerosis (MS) in 2004, revolutionizing treatment for this autoimmune disease?

The pharmaceutical industry has seen numerous groundbreaking product launches that have changed the face of medicine forever. These innovations have transformed patient care and created billion-dollar markets. Test your knowledge about one of the most significant medical product launches in recent history that revolutionized treatment approaches for millions of patients worldwide.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Biogen (Tysabri/natalizumab)
Novartis (Gilenya/fingolimod)
Merck (Rebif/interferon beta-1a)
Sanofi (Aubagio/teriflunomide)